Clinical Trials

16 studies in Colon and Rectal Surgery

  1. EARLY DETECTION OF BROKEN HEARTS IN CANCER PATIENTS: BEVACIZUMAB, SUNITINIB AND HEART FAILURE
    1. Minnesota
  2. Colorectal Polyp Discrimination Using High-Definition Narrow Band Imaging
    1. Florida
  3. A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
    1. Minnesota
  4. Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
    1. Minnesota
  5. Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
    1. Arizona
  6. An Open-Label, Multi-Center, Randomized Phase 1b/2 Study Of PF-05212384 Plus 5-Fluorouracil-Leucovorin-Irinotecan (FOLFIRI) Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer
    1. Minnesota
  7. A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
    1. Minnesota
  8. A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision
    1. Minnesota
  9. A Phase Ib Clinical Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
    1. Arizona,
    2. Minnesota
  10. A Phase 1b Open-Label Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis
    1. Minnesota
  1. 1
  2. 2
  3. Next